CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. EXCLUSIVE LICENSE AGREEMENT by and between Dr. Saul Yedgar and EDESA...Exclusive License Agreement • March 22nd, 2021 • Edesa Biotech, Inc. • Pharmaceutical preparations • London
This Agreement (“Agreement”), effective as of March 16, 2021 (“Effective Date”), is entered into by and between Saul Yedgar, an individual with principal residence at [___________] (“LICENSOR”), and Edesa Biotech Research Inc., an Ontario corporation with its principal office at 100 Spy Court, Markham, Ontario, L3R 5H6 (“EDESA”). LICENSOR and EDESA may be referred to herein individually as a “Party” or collectively as the “Parties”. Reference to a Party shall be deemed to include that Party’s Affiliates. [Principal residence of LICENSOR omitted.]
